Retrospective Database Analysis to Explore Patterns and Economic Burden of Switchback to Brand After Generic or Authorized Generic Utilization

BACKGROUND: Despite demonstration of bioequivalence of generics to brands and the potential for reduced costs, some patients switch back from a generic to the brand. A prior retrospective analysis suggested that this switchback rate may be lower among patients that had initially switched to authoriz...

Descripción completa

Detalles Bibliográficos
Autores principales: Alderfer, Justine, Aggarwal, Jyoti, Gilchrist, Kim, Alvir, Jose Maria Jimenez, Cook, Joseph, Park, Sang Hee, Stephens, Jennifer M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059206/
https://www.ncbi.nlm.nih.gov/pubmed/35509961
http://dx.doi.org/10.2147/CEOR.S319796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059206/
https://www.ncbi.nlm.nih.gov/pubmed/35509961
http://dx.doi.org/10.2147/CEOR.S319796

Ejemplares similares